Molecular Therapy Nucleic Acids · Nov 2026

Molecular engineering of zinc finger nucleases significantly enhances genome editing efficiency in cells

By Katayama S, Watanabe M, Kato Y et al.

Among the technologies used in the fields of biomedical sciences and medicine to edit genomes, zinc finger nucleases (ZFNs) are smaller in size than transcription activator-like effector nucleases and CRISPR-Cas9; therefore, ZFN-encoding DNAs are more easily packaged into viral vectors with a limited cargo space for in vivo delivery. Furthermore, ZFN patents expired in 2020, removing significant financial barriers to their clinical application. However, ZFNs with high genome editing activity are required. We previously increased the genome editing efficiency of ZFNs by 5% through targeted mutations; however, further enhancements were difficult. We herein significantly increased the genome editing efficiency of ZFNs by performing site-directed alanine scanning and using specific mutations identified using AlphaFold, Coot, and Rosetta. This structural engineering approach increased the baseline editing efficiency by up to 31% without increasing the off-target mutation rates. Our study provides a robust platform for high-efficiency, cost-effective genome editing using ZFNs, facilitating the next generation of clinical gene correction therapies.

doi.org/10.1016/j.omtn.2026.103179Open accessInterventions

AgingResearch.News